Inflammation

Probi pact looks to use probiotics to deliver needle-free vaccines

03-Jul-2020 By Will Chu

Probi, along with nine other Swedish firms, are to enter into a collaboration with Örebro University that looks to use probiotics as a needle-free delivery vehicle to transport vaccines into and across the body.

EPA-rich microalgal oil may slash cholesterol levels in healthy individuals: RCT

02-Jul-2020 By Stephen Daniells

Supplementation with an EPA-rich oil from Nannochloropsis microalgae may reduce total and very-low-density lipoprotein cholesterol (VLDL) levels in healthy people, says a new study using Qualitas Health’s AlmegaPL.

CBD Novel Foods deadline fast approaching as firms embrace regulatory challenges

02-Jul-2020 By Will Chu

With the UK Food Standards Agency (FSA) setting 31 March 2021 as the deadline for firms to have validated novel foods application for its CBD products, how are firms responding to this challenge especially in the current climate?

Juice boost: Why orange juice may be a potential non-dairy carrier for probiotics - study

01-Jul-2020 By Guan Yu Lim

Orange juice may be a potential non‐dairy based carrier for the probiotic Lactobacillus sanfranciscensis, according to a study conducted by researchers in Australia.

PLT says new boswellia ingredient solves flavor, solubility issues while expanding benefits to muscle recovery

26-Jun-2020 By Hank Schultz

PLT Health in concert with an Indian partner has launched a new boswellia ingredient whose flavor profile and solubility characteristics are claimed to open new doors for this longstanding botanical.

Calanus Oil included in Norway’s fish oil application to the Codex Alimentarius

24-Jun-2020 By Will Chu

Calanus announces its omega-3 rich oil is named in an application by Norway to the Codex Alimentarius Commission to include the product as a named oil in the Codex Standard for Fish Oils.

Norway asks industry for data about caffeine in cosmetic and care products

16-Jun-2020 By Will Chu

Norway’s food safety agency is asking industry for information about caffeine concentrations found in cosmetics and Personal Care Products (PCP) in a risk assessment to determine safe levels of caffeine exposure.

'Important' microbiome studies offer hope for IBD prediction

15-Jun-2020 By Nikki Hancocks

We may be able to predict disease relapse in patients with chronic inflammatory bowel diseases based on their microbiome markers, according researchers from APC Microbiome Ireland.

Microbiotica’s microbiome tech provides platform in landmark cancer-gut study

15-Jun-2020 By Will Chu

Microbiotica is to contribute its reference genome database and culture collection of gut bacteria in a landmark study looking at the microbiome’s role in patients undergoing treatment for various cancers.

Rousselot: ‘Collagen is moving beyond a specialised functional space’

11-Jun-2020 By Katy Askew

Collagen peptides are making their way into everyday use food categories, according to ingredients supplier Rousselot. Their inclusion in formulations allows manufacturers to differentiate with various health messages - and even unlocks the door to reformulation...

Mediterranean diet effective in IBD as part of multidimensional approach, says study

10-Jun-2020 By Will Chu

Patients with Crohn’s disease (CD) and ulcerative colitis (UC) could benefit from following a Mediterranean diet, after a study finds an impact on nutritional state and disease activity.

Eevia Health reopens production facility after €1m investment upgrade

03-Jun-2020 By Will Chu

Finnish producer Eevia Health Oy is to unveil the results of a €1m investment to its production facility as the firm pencils in an online reopening ceremony at the end of June.

Immunity advice for pharmacists: Blackmores publishes whitepaper on nutrition and supplement guidelines

03-Jun-2020 By Tingmin Koe

Blackmores has published a new whitepaper on nutrition guidelines for strengthening the immune system, preventing and treating respiratory tract infections – designed specifically for pharmacists.

Indena completes cosmetics business sale to Givaudan

02-Jun-2020 By Will Chu

Italian botanicals firm Indena completes the sale of its nutricosmetics business to Swiss-based Givaudan in a deal that began in 2019 and introduces a manufacturing and innovation pact between the two firms.

Newly identified ‘metabolic signature’ can determine adherence to Mediterranean diet, help predict CVD risk

28-May-2020 By Nikki Hancocks

A newly identified “metabolic signature” can evaluate an individual’s adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research.